JP2015516943A - ポリペプチド及びその使用 - Google Patents

ポリペプチド及びその使用 Download PDF

Info

Publication number
JP2015516943A
JP2015516943A JP2014561504A JP2014561504A JP2015516943A JP 2015516943 A JP2015516943 A JP 2015516943A JP 2014561504 A JP2014561504 A JP 2014561504A JP 2014561504 A JP2014561504 A JP 2014561504A JP 2015516943 A JP2015516943 A JP 2015516943A
Authority
JP
Japan
Prior art keywords
malassezia
polypeptide
sequence
product
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014561504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015516943A5 (enExample
Inventor
オニール，デボラ
マーサー，デリー
スチュアート，コリン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NovaBiotics Ltd
Original Assignee
NovaBiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NovaBiotics Ltd filed Critical NovaBiotics Ltd
Publication of JP2015516943A publication Critical patent/JP2015516943A/ja
Publication of JP2015516943A5 publication Critical patent/JP2015516943A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Polyamides (AREA)
JP2014561504A 2012-03-14 2013-03-14 ポリペプチド及びその使用 Pending JP2015516943A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1204457.4 2012-03-14
GBGB1204457.4A GB201204457D0 (en) 2012-03-14 2012-03-14 Polypeptides and their use
US201261620833P 2012-04-05 2012-04-05
US61/620,833 2012-04-05
PCT/GB2013/000112 WO2013136040A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use

Publications (2)

Publication Number Publication Date
JP2015516943A true JP2015516943A (ja) 2015-06-18
JP2015516943A5 JP2015516943A5 (enExample) 2016-05-12

Family

ID=46026493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014561504A Pending JP2015516943A (ja) 2012-03-14 2013-03-14 ポリペプチド及びその使用

Country Status (17)

Country Link
US (1) US20140155321A1 (enExample)
EP (1) EP2825261A1 (enExample)
JP (1) JP2015516943A (enExample)
KR (1) KR20140138940A (enExample)
CN (1) CN104428036A (enExample)
AU (1) AU2013234122A1 (enExample)
CA (1) CA2866837A1 (enExample)
CL (1) CL2014002397A1 (enExample)
GB (1) GB201204457D0 (enExample)
HK (1) HK1201050A1 (enExample)
IL (1) IL234646A0 (enExample)
MX (1) MX2014010996A (enExample)
NZ (1) NZ700467A (enExample)
RU (1) RU2014139857A (enExample)
SG (1) SG11201405539QA (enExample)
WO (1) WO2013136040A1 (enExample)
ZA (1) ZA201407276B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017047299A1 (ja) * 2015-09-15 2017-03-23 富士フイルム株式会社 注射用液剤組成物
JP2024082709A (ja) * 2022-12-09 2024-06-20 日本メナード化粧品株式会社 抗菌剤

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2981037C (en) * 2015-04-03 2019-04-30 Elc Management Llc Hair treatment compositions comprising hydrolyzed wheat protein and polyquaternium-6
JP6553961B2 (ja) * 2015-06-25 2019-07-31 花王株式会社 美白剤
CN109700834A (zh) * 2019-01-18 2019-05-03 上海市农业科学院 一种蛹虫草固体发酵物及其抗菌用途
AR122485A1 (es) 2020-06-04 2022-09-14 Syngenta Crop Protection Ag Composiciones fungicidas
CN115381928B (zh) * 2022-10-27 2022-12-27 山东中医药大学附属医院 一种真菌提取物在制备溃疡性结肠炎治疗药物中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010517988A (ja) * 2007-02-02 2010-05-27 ノバビオティクス・リミテッド ペプチドおよびその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1927597T3 (en) * 2004-08-18 2017-02-13 Novabiotics Ltd ANTIBACTERIAL PEPTIDES
GB0611115D0 (en) * 2006-06-06 2006-07-19 Novabiotics Ltd Compounds and their use
GB0702022D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
EP2224901A1 (en) * 2007-12-21 2010-09-08 Basf Se Anti-dandruff compositions containing peptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010517988A (ja) * 2007-02-02 2010-05-27 ノバビオティクス・リミテッド ペプチドおよびその使用

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017047299A1 (ja) * 2015-09-15 2017-03-23 富士フイルム株式会社 注射用液剤組成物
JPWO2017047299A1 (ja) * 2015-09-15 2017-12-21 富士フイルム株式会社 注射用液剤組成物
JP2024082709A (ja) * 2022-12-09 2024-06-20 日本メナード化粧品株式会社 抗菌剤

Also Published As

Publication number Publication date
RU2014139857A (ru) 2016-05-10
CA2866837A1 (en) 2013-09-19
HK1201050A1 (en) 2015-08-21
EP2825261A1 (en) 2015-01-21
CL2014002397A1 (es) 2015-02-27
IL234646A0 (en) 2014-11-30
US20140155321A1 (en) 2014-06-05
WO2013136040A1 (en) 2013-09-19
CN104428036A (zh) 2015-03-18
KR20140138940A (ko) 2014-12-04
AU2013234122A1 (en) 2014-10-16
SG11201405539QA (en) 2014-10-30
GB201204457D0 (en) 2012-04-25
NZ700467A (en) 2016-08-26
ZA201407276B (en) 2015-06-24
MX2014010996A (es) 2014-10-13

Similar Documents

Publication Publication Date Title
US20190142800A1 (en) Synergistic antifungal compositions and methods thereof
ES2729237T3 (es) Lipopéptidos antimicrobianos cortos
US20140155321A1 (en) Polypeptides and Their Use
JP2017002057A (ja) 抗菌ペプチド、組成物及びその使用方法
CN110538313B (zh) 一种广谱抗马拉色菌的天然产物组合物及应用
CN105431154A (zh) 抗菌成分
US20130131121A1 (en) Anti-viral agent
KR101449129B1 (ko) Ａｂｈ 항원의 발현을 조절하는 물질을 포함하는 조성물
EP3982909A1 (en) Compositions and methods for the antiseptic treatment of biofilms on mammalian tissue
JP2009167139A (ja) 外用組成物
AU2019286511B2 (en) Enhancement of antibacterial actions of a depsipeptide antibiotic using synergistic amounts of boric acid
JP2013151442A (ja) 哺乳類が分泌する抗菌ペプチド分泌促進剤
KR20110086466A (ko) 신규한 항생제 조성물 및 그람양성균의 치료 방법
AU2012250489B2 (en) Avian-based treatment for microbial infections
US8192750B2 (en) Pharmaceutical composition for the treatment of otomycosis
JP7590833B2 (ja) 皮膚外用組成物
US20250352515A1 (en) Topical formulations
CN118697851A (zh) 一种宠物用复方酮康唑制剂及其制备方法
JP2007091643A (ja) 医療用抗白癬菌剤
CN111228465A (zh) 一种治疗痤疮的药物
WO2005099731A1 (ja) 生薬由来の抗菌剤及びこれを含有する外用組成物
HK1138773A (en) Anti-viral agent
RO122622B1 (ro) Produs farmaceutic sub formă de gel

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160311

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161206

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170627